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ABSTRACT: A route to the accelerated nucleation of α-para-aminobenzoic acid in ethanol/water (EtOH/H2O) mixed solvent
solutions, using antisolvent crystallization, is presented. An isothermal by design approach is adopted, whereby the exothermic
enthalpy of mixing associated with antisolvent addition is oﬀset by the control of the temperature of the antisolvent added.
Induction times (τ) are found to be reduced by 4 orders of magnitude using this methodology, consistent with the use of this
approach as a nucleation acceleration technique. Calculation of the nucleation kinetic parameters for a range of solution
concentrations, compositions, and supersaturations (S) reveal that eﬀective interfacial tensions (γeff) vary from 8.4 to 2.3 mJ
m−2 from solutions in H2O solvent and EtOH solvent, respectively, in line with the trend in solubility. The critical nucleus
radius (r*) decreases from 1.98 to 0.40 nm associated with a decrease in the number of molecules in the critical nucleus (i*)
from 196 to 2 molecules. A change in nucleation mechanism from heterogeneous nucleation to homogeneous nucleation is
observed to take place at S ≈ 1.5. Limitations, particularly with focus toward larger-scale operation, are highlighted together
with potential solutions to overcome such aspects.
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1. INTRODUCTION
Crystallization is a highly energy-eﬃcient key unit operation
for isolation and puriﬁcation in the manufacture of drugs,
pigments, agrochemicals, confectionary, and other ﬁne
chemicals.1 Nevertheless, crystallization can also be an
unwanted phenomenon, for example, in cases such as fuels
operating in cold weather or drugs stabilized in highly
concentrated liquid formulations.2
The driving force for crystallization is supersaturation, and
this process encompasses two distinct transformational
stagesnucleation and growth.3 In solution crystallization,
nucleation signiﬁes the structural pathway by which solute
molecules cluster together to form 3-D nuclei; when these
nuclei achieve a critical cluster size, termed the critical nucleus
radius (r*), with a deﬁned number of molecules in the critical
nucleus (i*), growth is favored.
Nucleation can be divided into two categories: heteroge-
neous nucleation (HEN) and homogeneous nucleation
(HON). HEN is caused when sites, usually suspended particles
or impurities in the solution, provide a surface for nucleation,
whereas HON describes spontaneous nucleation within the
bulk solution.4 Nucleation behavior can be modeled by
classical nucleation theory (CNT), enabling the expression of
the rate at which nucleation occurs (J) through an Arrhenius
reaction rate equation3
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which indicates that there are three main contributors to the
rate of nucleation: temperature (T), degree of molar
supersaturation (S), and interfacial tension (γ).3 Further
parameters in the equation include the pre-exponential factor,
A, the volume occupied by a solute molecule in a crystal, v0,
and the Boltzmann constant, k.
Nucleation can occur in an inﬁnitesimally short time frame
or it can take a period of years. This uncertainty means that
tests are currently performed to screen crystalline products,
which might undergo nucleation events with signiﬁcant impact
upon product performance, such as polymorphic screening,5
which includes solution crystallization using an array of
solvents as well as relatively high supersaturation conditions.
However, these tests cannot, as yet, predict if/when a
nucleation event may take place over an extended period of
time, which would constitute a “slowly nucleating system”,
because of the timescale of a nucleation event being longer
than could be routinely tested under current realistic
experimental time frames in both academic and industrial
settings. There are a number of examples of slowly nucleating
systems, including citric acid in water,6 fats,7 conversion of
diamond to graphite, drug products,8 etc. If tests could be
implemented to predict this, then perhaps steps might be taken
to mitigate an unforeseen nucleation event either through
nucleation inhibition9 or by formulating a diﬀerent solid
form.10
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In chemical stability studies, accelerated approaches have
been used in order to understand and hence predict properties,
such as stability or reactivity, through the application of
elevated thermodynamic conditions. In this, products are held
at relatively high temperatures for a short period to emulate the
eﬀect of storage at room temperature for an extended period.11
In a similar manner, an accelerated methodology could be
employed to predict nucleation events of slowly nucleating
systems, involving the process of increasing the rate of
nucleation through solution crystallization at high super-
saturations. Numerous avenues exist to try and achieve this,
such as antisolvent crystallization (also known as drown-out
crystallization),12−14 crash cooling crystallization,15 sono16−18
and/or gassing19,20 crystallization, or templated crystalliza-
tion.21−23 Each of these techniques produces a higher
nucleation rate than could perhaps be achieved through
standard crystallization processes, such as cooling, isothermal,
or evaporative crystallization processes. Although each
technique has diﬀerent intricacies related to various methodo-
logical aspects, antisolvent crystallization has been shown to
yield eﬀective high supersaturation results with relative ease,5,12
and therefore was used during this study.
In antisolvent crystallization, two completely miscible
solvents, each with substantial diﬀerence in the solubility for
the solute, are used. The solute is crystallized by isothermally
adding the low solubility solvent (antisolvent) to a
concentrated solution of the other, with the diﬀerence in
solubility increasing the solution supersaturation and, as such,
driving the crystallization process. Antisolvent crystallization
has been studied extensively with a diﬀerent focus on the eﬀect
it has upon certain crystallization systems, such as diﬀerent
addition ﬂow rates,24 solvent composition,25 polymorphism,26
crystal size distribution,27 antisolvent control,28 combined
cooling and antisolvent crystallization (CCAC),29 and
antisolvent in continuous crystallizers.30 Although this process
has been well studied, a simple methodology to apply this
approach to screen potential crystallizing systems and measure
their kinetics has not, as of yet, been proposed.
A signiﬁcant problem with performing antisolvent crystal-
lizations for isothermal nucleation kinetic analysis, however, is
that when a second solvent is added to a solution, there is
usually an exothermic enthalpy of mixing, which can cause
considerable increases in the overall solution temperature.
Such variations in solution temperature can make it quite
challenging to derive meaningful nucleation kinetics from the
analysis of such data. This is particularly problematic for the
case of crystallization at relatively high solution super-
saturations, where crystallization occurs quite rapidly, and
also where the enthalpy of mixing is much higher because of
the greater amount of added antisolvent.
Because of the dynamics of heat transfer, regulation of
reactor temperature is not really a feasible option for process-
scale reactions given the diﬃculties associated with the
homogeneity of solution temperatures in large-scale vessels,
especially with fast changes in solution temperature, given the
conductive heating control of reactor jackets.2,31−34 An
alternative approach is to oﬀset the temperature of the
antisolvent that is added to the solution in a manner so as to
aﬀect a heat balance associated with the enthalpy of mixing,
hence ensuring both isothermal conditions and high super-
saturations. This approach is described through the nomen-
clature“isothermal by design” (IbD). The IbD concept is
demonstrated in this paper through a study of the accelerated
nucleation of α-p-aminobenzoic acid (pABA) from aqueous
ethanol solution through an aqueous antisolvent addition. In
such an experiment, the time to crystallize after antisolvent
addition, the induction time (τ), can be measured to determine
how quickly nucleation occurred. pABA in aqueous ethanol
solution with an aqueous antisolvent was chosen for this study
because of the large amount of work carried out on pABA in
this research group providing data on key nucleation
parameters and solubility eﬀects to compare the current;35−37
previous studies have determined that the metastable zone
width of pABA was relatively large in the EtOH solvent, and as
such, it could be used as a model system for the determination
of a possible nucleation acceleration methodology and also as
it represents a model pharmaceutical compound and solvent
system. A good review of the crystallization science of pABA is
described in a previous study.35
The structure of the paper is as follows:
After this introduction, the methodology workﬂow is
presented, followed by results, discussion and conclusions.
2. MATERIALS AND METHODS
A workﬂow detailing the steps required for the IbD approach
for any system of study is given in Figure 1.
2.1. Materials. pABA (99% pure) was supplied by Alfa
Aesar, ethanol absolute (≥99.8% pure) was supplied by VWR,
and deionized water was sourced on site at the University of
Leeds.
Figure 1. Workﬂow detailing the consistent steps required in order to perform the IbD approach for any system of study.
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2.2. Experimental Procedure. All the crystallization and
dissolution experiments were carried out using the Technobis
Crystal 16 system,38 which records transmission data as a
function of the temperature and time. A temperature
calibration of the system was performed to ensure that correct
temperature measurements were both taken and set under the
experimental procedures undertaken.
Solubility of pABA in EtOH/H2O mixed solutions was
determined prior to antisolvent addition experiments.
Solutions were prepared at a minimum of four solution
concentrations, with the concentrations used dependent upon
the solvent composition. Eleven solvent compositions ranging
in 10 wt % increments of EtOH from pure EtOH to pure H2O
were used. Solutions were weighed on a balance with ±0.1 mg
accuracy and heated to 333 K at 300 rpm for 1 h to ensure
total homogenization of the solution. The solution (1 mL) was
then transferred to 1.5 mL disposable glass vials for use in the
experimental apparatus, which contained 7 mm × 2 mm
magnetic stirrers, using a Fisherbrand 100−1000 μL micro-
pipette with preheated pipette tips (303 K) to prevent
unwanted crystallization.
The 1 mL solutions were subject to diﬀerent cooling and
heating cycles between 333 and 278 K at set rates (q, where q
= 0.3, 0.5, 0.7, and 1 K min−1), while stirring at 600 rpm.
Crystallization (Tc) and dissolution (Tdiss) temperatures as
well as crystallization temperatures at the kinetic limit (Tc,l)
and equilibrium saturation temperatures (Te) were determined
from transmission data, with the methodology undertaken to
determine each of these parameters described in the previous
literature.39
A van’t Hoﬀ analysis was performed from the obtained
solubility data to determine how the system of study deviated
from ideality, with the ideal solubility of pABA obtained from
the previous literature,36 based upon the Hildebrand equation
(eq 2). Activity coeﬃcients (Y) and enthalpy (ΔHdiss) and
entropy (ΔSdiss) of dissolution were calculated based on the
following equations, which have been derived in the previous
literature39
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where xideal is the solution concentration, x is the
experimentally measured molar solubility, ΔHfus is the enthalpy
of fusion, R is the ideal gas constant, T is the temperature, and
Tm is the melting temperature.
For antisolvent calorimetry experiments, all solutions were
prepared to ensure a saturation temperature of 293 K for a
mixed solvent solution of 70 wt % EtOH:30 wt % H2O EtOH/
H2O and pABA. This temperature was chosen at it was low
enough to ensure minimal solvent evaporation during the
experiments. The solvent composition was selected because of
solubility studies highlighting that small additions of H2O to
pABA in EtOH solution increased the solubility, whereas over
the temperature range used, any addition of H2O to a 70 wt %
EtOH:30 wt % H2O composition only decreased the solubility,
while providing a large range of solvent compositions to be
examined in the performed experiments. Solution volumes
used ranged from 0.80 to 0.20 mL in 0.05 mL increments, with
all solution volumes made up to 1 mL after antisolvent
addition.
Calibrations based upon solution calorimetry were per-
formed to ensure an IbD approach, with 5 initial volumes
selected for the calibration at a selected temperature (ranging
from 293 to 301 K in 2 K increments), with four diﬀerent
antisolvent temperatures selected. Solutions were held at
constant temperature, stirring at 900 rpm, with the antisolvent
held at constant temperature, stirring at 700 rpm. The
calibrations were performed by placing a digital thermometer
into the solution vials and then withdrawing the full antisolvent
volume with a 1 mL syringe with an attached needle and
transferring the contents into the solution vial rapidly, inducing
high mixing. The speed of addition meant that the antisolvent
was added almost instantaneously, leading to this procedure
being described as “instant addition”. The temperature of the
solution was recorded after each addition by taking the value of
the highest recorded temperature on the digital thermometer
within 1 s after antisolvent addition. Each calibration was
repeated four times. Plots of selected antisolvent temperatures
against the temperature of solutions after antisolvent addition
were made and linear regressions were plotted with
extrapolations to the desired solution temperature, indicating
the required antisolvent temperature to maintain the solution
temperature upon addition. This was then used to determine
which antisolvent temperature should be used for each
induction time experiment at that temperature. This was
subsequently tested to ensure that the calibrations were
accurate and that the solution temperatures were maintained
upon addition of the antisolvent at the determined calibration
temperatures. It was observed that deviations in solution
temperature upon addition of H2O, over a range of four
repeats, were at most ±0.2 K, with solutions quickly returning
to set temperatures in a manner of a few seconds. Therefore,
this eﬀect was deemed to be negligible.
After the calorimetry calibrations were completed, the
induction time experiments were performed. The same
procedure was undertaken as described for the calibrations,
leading to an “instant addition” methodology; however, all
selected solution volumes were used, antisolvent temperatures
were selected based upon the calibrations, and no digital
thermometer was placed in the vials, ensuring no eﬀect on
nucleation by introducing another surface on which to
crystallize upon. Sixteen repeats were performed for each
initial solution volume used at each selected temperature. The
induction time to nucleation was determined from the
collected transmission data.
The isothermal transmittance data were used to calculate the
time between when the antisolvent was added to the vials and
when nucleation had occurred, giving the induction time. The
point at which the antisolvent was added was also determined
by the transmission data. This process is described in
Supporting Information S3, along with a more detailed
description of the experimental procedures undertaken.
2.3. Analysis of Nucleation Kinetics and Mechanism.
Molar supersaturations for each solution were calculated
according to
=
*
S
c
c (5)
where c is the absolute solute concentration and c* is the
saturation concentration.
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The rate of nucleation was taken to be related to the
induction time obtained from the experiments under the
relationship described through the equation3
τ ∝ −J 1 (6)
The induction time data (τ as a function of S) were analyzed
using CNT4,40 according to
τ{ [ − ] }
= +
[ + ]
+S S
k
B
md kT S
ln ( 1)
ln
(1 )( ln )
md md
md
1/1
2 (7)
Ä
Ç
ÅÅÅÅÅÅÅÅÅÅÅÅ
É
Ö
ÑÑÑÑÑÑÑÑÑÑÑÑ
α= +*
+
k
md
k zf c d f
(1 )
md d md
md
det
v e s 0 e,s
1/(1 )
(8)
π γ
=B
v
kT
16
3
0
2
eff
3
(9)
where m is the crystallite growth exponent, with m = 1 for
pABA,35 d is related to the dimensionality of crystal growth,
with d = 1 for pABA,35 αdet is the fraction of detectable
crystallized volume, kv is the crystallite growth shape factor, z is
the Zeldovich factor, fe* is the frequency of monomer
attachment to the nucleus at Δμ = 0, cs is the solution
concentration at the crystal solution interface, d0 is the
molecular diameter ≈ (6vo/π)1/3, fe,s is the frequency of
molecular attachment per growth site at Δμ = 0 and γeff is the
eﬀective interfacial tension.
A derivation of eq 7 is given in a previous research article.41
ln{τ[S(S − 1)md]1/1+md} was plotted as a function of 1/T3(ln
S)2 and a linear regression was ﬁtted through the data, with the
slope (SLlin) equating to
π γ
+
v
md k
16
3(1 )
0
2
eff
3
3 . This enabled the
calculation of the eﬀective interfacial tension. From this, the
critical nucleus radius (r*) and the number of molecules in the
critical nucleus (i*) were calculated
γ
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v
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Plots of (log S)−2 versus log τ were constructed to determine
if a nucleation mechanism change occurred during the
nucleation at higher supersaturations, given that
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Large increases in the linear ﬁt slopes would suggest a
change from HEN, at lower supersaturations, to HON, at
higher supersaturations.3
3. RESULTS AND DISCUSSION
3.1. Solubility Analysis. Small additions of H2O to pure
EtOH solutions were seen to increase pABA solubility,
followed by a subsequent decrease in solubility after further
addition (Figure 2). This eﬀect has been noted in previous
research performed by Rosbottom et al.37 for pABA in mixed
EtOH/nitromethane (NMe) solutions. The eﬀect is temper-
ature-dependent, with higher temperatures resulting in a more
dramatic increase in solubility, and at lower temperatures, the
increasing solubility with H2O addition does not occur and the
solubility of the system is the highest in pure EtOH.
van’t Hoﬀ analysis provides information on the interactions
between the solute and solvent molecules. In an ideal solution,
the interactions are all the same, but a positive deviation from
ideality indicates that solute−solvent interactions are the
strongest, whereas negative deviations suggest that solute−
solute interactions are the strongest and dominate the solution.
Solubility data obtained for varying solution compositions
(Figure 3) easily ﬁt a linear regression model; this along with
visual inspection of the crystals and no previous ﬁnding of
other pABA polymorphs than the alpha form crystallizing from
ethanolic solutions indicated that there was no diﬀerence in
the solid-state form of pABA over the range of temperatures
used.
The values of the enthalpy (ΔHdiss) and entropy (ΔSdiss) of
dissolutions calculated from the slope and y-axis intercepts of
the van’t Hoﬀ plots, respectively, and the linear dependence of
the calculated activity coeﬃcients (Y) on the experimentally
measured molar solubility (x) are displayed in Table 1. Less
than ideal behavior was observed for all pABA EtOH/H2O
solutions with values of Y for all solutions found to be above 1
over the temperature range of 283−323 K, demonstrating that
the solute−solute interactions were the strongest. However,
the gradient of the plots was not all found to be equal to that of
the ideal solution, showing that at lower temperatures, some
solutions show more than ideal behavior, although this does
not occur until, for example, 274 K for the pure EtOH
solution. This change was also observed for pABA solutions in
a mixed EtOH/NMe solvent in a previous study.37 It is
noticeable that the solution behavior of pABA in EtOH
deviates largely from those containing some/only H2O (Figure
5b). This diﬀerence in solution behavior could be due to the
diﬀerent solvation energies for pABA in EtOH and H2O.
36 The
fairly comparable slopes of the mixed solvent and pure H2O
solvent solutions demonstrate that for these solutions the
entropic component was changing, whereas for pure ethanolic
solvent solutions, the enthalpic component was changing. The
enthalpic gradient observed for the pure ethanolic solution is
Figure 2. Solubility of pABA in EtOH/H2O mixtures at diﬀerent
temperatures collected by dissolution studies. 323 K (pink ▼), 313 K
(blue ▲), 303 K (red ●), and 293 K (black ■).
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consistent with the determined solubility data, corroborating
the ﬁnding that at higher temperatures, small additions of H2O
increase the solubility, whereas at lower temperatures, this
eﬀect does not occur. Turner et al.36 calculated the values of Y
for pABA in EtOH and H2O to be 1.10 and 63.05, respectively,
which correlates strongly with the calculated values here, with
61.7 < Y < 87.5 for H2O in the temperature range 300−321 K
and 1.4 < Y < 2.1 for EtOH in the temperature range 293−324
K, providing conﬁdence in the reported values.
3.2. CalorimetryEﬀect of Antisolvent Temperature.
The addition temperature of H2O to pABA in EtOH/H2O
mixed solvent solutions was found to have a large impact on
the solution temperature, providing evidence of just how
pronounced the eﬀect of controlling antisolvent temperature
can be. The amount by which the antisolvent temperature
altered the solution temperature varied depending upon the
amount added, with a greater volume of antisolvent having a
larger impact on the solution temperature (Figure 4).
A total calibration for solution volumes and temperatures
was created (Figure 5) to enable the IbD approach to this
study. It is worth mentioning that these calibrations are speciﬁc
to this system and experimental setup, with diﬀerent pieces of
equipment yielding potentially diﬀerent results based upon
heat-transfer eﬃciency, mixing, etc.
Discrepancies in nucleation induction time results, obtained
when the antisolvent temperature was controlled through the
described methodology compared to the uncontrolled
antisolvent temperature, where the antisolvent was held at
the same temperature as the solution (Figure 6) were found to
be large. For the controlled antisolvent temperature, the
induction times were mainly much smaller than for the
Figure 3. van’t Hoﬀ plot for pABA in EtOH/H2O mixed solvent solutions. Dashed black line represents ideal solubility, and solid lines represent
experimental solubilities for diﬀerent solvent compositions: 100 wt % EtOH (blue cross), 90 wt % EtOH (brown vertical line), 80 wt % EtOH
(lavender pentagon), 70 wt % EtOH (brown star), 60 wt % EtOH (green plus), 50 wt % EtOH (violet right-pointing triangle), 40 wt % EtOH
(green left-pointing triangle), 30 wt % EtOH (green diamond), 20 wt % EtOH (pink down-pointing triangle), 10 wt % EtOH (blue up-pointing
triangle), and 100 wt % H2O (red circle). (a) Plots for all compositions studied. (b) Plot over a smaller range of molar solubility, showing more
clearly the variation observed with EtOH solubility as a function of temperature.
Table 1. Thermodynamic Parameters Together with Linear
Dependence of Y on x Derived from Solubility Analysis for
Varying Compositions of pABA in EtOH/H2O Solutions
thermodynamic parameters
ΔHdiss
(kJ mol−1)
ΔSdiss
(kJ K−1 mol−1) ln Y = ax + b
H2O −30.64 0.041 −0.32 ln x + 2.07
10:90
EtOH/H2O
−35.93 0.062 −0.42 ln x + 1.09
20:80
EtOH/H2O
−39.47 0.080 −0.47 ln x + 0.32
30:70
EtOH/H2O
−33.37 0.067 −0.38 ln x + 0.35
40:60
EtOH/H2O
−24.82 0.046 −0.16 ln x + 0.82
50:50
EtOH/H2O
−28.06 0.058 −0.28 ln x + 0.13
60:40
EtOH/H2O
−21.01 0.039 −0.004 ln x + 0.8
70:30
EtOH/H2O
−14.13 0.019 0.36 ln x + 1.73
80:20
EtOH/H2O
−15.93 0.025 0.31 ln x + 1.45
90:10
EtOH/H2O
−14.74 0.021 0.41 ln x + 1.77
EtOH −7.99 −0.001 1.55 ln x + 5.65
Figure 4. Eﬀect of antisolvent temperature on solutions of pABA in
the EtOH/H2O mixed solvent held at constant temperature (297 K).
Eﬀect of antisolvent temperature on 0.2 mL initial solution (green
diamond), 0.3 mL initial solution (pink down-pointing triangle), 0.5
mL initial solution (blue up-pointing triangle), 0.65 mL initial
solution (red circle), and 0.8 mL initial solution (black square) shown
by the gradients of the linear relationships.
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experiments performed without control, which can be
attributed to the heat of mixing increasing the solution
temperature for uncontrolled experiments and as such
decreasing the supersaturation, before subsequent slow and
uncontrolled cooling to the solution set temperature as the
experimental system reequilibrated the solution temperature.
Furthermore, the standard deviations of the controlled
experiments were much lower than that of the uncontrolled
experiments. This was due to the IbD approach in the
controlled experiments, indicating that deviations in results
were due to the stochasticity of nucleation as opposed to the
added eﬀect of temperature variations, which was a component
of the uncontrolled experiments.
It is noticeable that lower initial solution volumes have a
lower standard deviation than higher initial solution volumes.
This is due to the higher initial solution volumes generating a
lower supersaturation, as less antisolvent was added, and as
such, this lower driving force generates more variation in the
stochasticity of nucleation. This will be discussed in more
detail in the next section.
3.3. Compositions, Concentrations, and Supersatura-
tions. The experimental methodology applied to accelerating
nucleation was able to cover a wide range of solution
compositions from 11 to 53 wt % EtOH, concentrations
from 22.4 to 104.3 g pABA kg−1 solvent, and supersaturations
from 1.08 to 4.73 (Table 2). It is important to note that other
systems studied through this methodology could achieve
diﬀerent and potentially greater variations in compositions and
concentrations, as well as higher supersaturations, which will
be discussed in Section 4.2 of this article.
An overall nonlinear decreasing trend of τ with increasing
supersaturation and hence an increased rate of nucleation
(Figure 7), for pABA crystallizing from EtOH/H2O mixtures,
were observed. At high solution supersaturations, changes in τ
were smaller than at lower supersaturations, where even small
changes in S had a pronounced eﬀect on induction times.
At relatively low supersaturations, high standard deviations
in induction time results were observed. This stochasticity and
lack of reproducibility of induction time measurements at low
S have led to the use of probability distribution functions in
induction time studies to determine nucleation parameters,42
indicating that a very large number of repeats are needed for
each supersaturation used. However, because of supersatura-
tion being the driving force for crystal nucleation, it was seen
that at the higher supersaturations and lower induction times,
where the stochastic nature of nucleation is slightly overcome,
the results were more reproducible, with less deviation from
one experiment to the next (Figure 8).
For all concentrations and compositions used, it is
noticeable that the change in induction times using the
proposed method was substantial, with changes from periods
of hours to seconds (Figure 7b). Furthermore, it provides
signiﬁcant information regarding when crystallization would
occur at diﬀerent supersaturations, indicating that great control
could be achieved over the process of pABA crystallizing from
EtOH/H2O solutions. This “control” could be of considerable
impact to systems that are required to remain uncrystallized for
a certain duration of time or conversely need to crystallize at a
speciﬁc time, such as diesel fuel, agrochemical products,
pharmaceutical supersaturated dosage forms, and so forth.
Furthermore, high supersaturations were achieved at a very
fast rate under this “instant addition” methodology unlike
other crystallization methodologies to produce high super-
saturations, such as crash cooling, which can take minutes to
reach a desired level of supersaturation43 and, as such, can be
subject to unwanted crystallization before the level is reached.
This was very important for the higher supersaturation
experiments performed as the induction times themselves
were only one or more seconds, indicating that other
methodologies might not have been able to produce such a
supersaturation level for the system of study, such as
conventional cooling crystallization, evaporative crystallization,
isothermal crystallization, and so forth. For example, for pABA
in EtOH, in order to achieve S = 2 at 293 K, a saturation
Figure 5. Antisolvent temperature calibration for the addition of
water to pABA in the 70:30 wt % EtOH/H2O solution held at set
temperatures [301 K (green diamond), 299 K (pink down-pointing
triangle), 297 K (blue up-pointing triangle), 295 K (red circle), and
293 K (black square)] in order to maintain solution temperatures.
The temperature of the antisolvent is plotted against the initial
amount of solution used.
Figure 6. Diﬀerence in induction time measurements for uncontrolled
(black square) and controlled (red circle) antisolvent temperature
addition for a solution temperature of 295 K. Error bars show
standard deviation of repeats. Trend lines ﬁtted for both data sets to
highlight deviation.
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temperature of 359 K was required, which is above the boiling
point of EtOH, indicating that normal isothermal approaches
are not feasible, providing further evidence of the beneﬁts of
this IbD antisolvent approach to achieving high super-
saturations.
An alternative explanation to how induction times were
reduced substantially under the proposed IbD methodology is
that “cold spots” were created upon addition of the colder
antisolvent to the higher temperature solution, creating areas
of localized high supersaturations. However, given that the
mixing times would be short in comparison to the induction
times, even at higher solution supersaturations, this is not likely
to be the case. High supersaturations and low induction times
were achieved by direct mixing of the antisolvent with the
solution and subsequent homogeneity of solution temperature
in a very short time period before subsequent nucleation.
Nevertheless, at larger scales, such as industrial scales, this
could be a problem because of diﬃculties in mixing and
temperature regulation.31,34 This will be discussed further in
Section 4.3.
A comparative method to IbD outlined here is combined
cooling and antisolvent crystallization (CCAC),29 which
Table 2. Solution Compositions, Concentrations, and Supersaturations over the Range of Initial Solution Volumes Selecteda
initial
solution
volume
(mL)
ﬁnal
solution
H2O
content
(wt %)
ﬁnal solution
EtOH
content
(wt %)
ﬁnal solution
concentration
(g pABA kg−1 solution)
supersaturation at
solution
temperature of
293 K
supersaturation at
solution
temperature of
295 K
supersaturation at
solution
temperature of
297 K
supersaturation at
solution
temperature of
299 K
supersaturation at
solution
temperature of
301 K
0.8 47 53 104.3 Fr 1.08 nc nc nc
0.75 51 49 96.5 Fr 1.15 1.09 nc nc
0.7 55 45 88.9 Fr 1.25 1.17 1.10 nc
0.65 59 41 81.4 Fr 1.37 1.28 1.20 1.12
0.6 62 38 74.2 Fr 1.51 1.41 1.32 1.23
0.55 66 34 67.2 1.82 1.69 1.57 1.46 1.36
0.5 69 31 60.3 2.06 1.91 1.77 1.64 1.52
0.45 73 27 53.6 2.36 2.18 2.01 1.86 1.72
0.4 76 24 47.0 2.72 2.51 2.31 2.12 1.96
0.35 79 21 40.7 3.16 2.90 2.66 2.44 2.24
0.3 83 17 34.4 3.68 3.36 3.07 2.80 2.55
0.25 86 14 28.4 4.25(lv) 3.85(lv) 3.49(lv) 3.16(lv) 2.86(lv)
0.2 89 11 22.4 4.73(lv) 4.23(lv) 3.79(lv) 3.40(lv) 3.06(lv)
a“fr” denotes solutions where the required antisolvent temperature to maintain the solution temperature was too low and would cause the water
antisolvent to freeze. “nc” denotes solutions that would not crystallize because of too low supersaturations. “lv” denotes solutions that underwent
the described experimental procedure but where the solution volume was too low for accurate induction time detection. “Final solution” refers to
the solution after antisolvent addition.
Figure 7. Induction time vs supersaturation for pABA in EtOH/H2O mixture solutions, with error bars showing standard deviation of 16 repeats
for each data point. (a) Data obtained at a ﬁnal solution concentration of the 67.2 g pABA kg−1 solvent mixture at all temperatures and (b) all
concentrations and compositions at all temperatures (log scale used for the y-axis).
Figure 8. Change in standard deviation of induction time measure-
ments, over 16 repeats, as a function of supersaturation.
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utilizes a polythermal cooling crystallization methodology with
a controlled addition of antisolvent to achieve high super-
saturations. The advantages of IbD over CCAC are twofold:
IbD is simpler compared to CCAC, with just control of
antisolvent temperature being prevalent as opposed to trying
to control the cooling rate, enthalpies of mixing, and
antisolvent addition rate, all at once. Also, IbD utilizes direct
mixing to maintain the solution temperature, whereas CCAC
utilizes conduction cooling from a reactor jacket, which can
cause diﬃculties in solution homogeneity at larger industrial
scales, as discussed in the Introduction section.
3.4. Nucleation Kinetics Analysis. Induction time (τ)
data were collected as a function of supersaturation (S) for a
range of concentrations and compositions of pABA in EtOH/
H2O mixed solutions. The data collected were used to
calculate interfacial tensions (γeff) for solution concentrations
between 88.9 and 34.4 pABA kg−1 solvent mixture using eq 7
and the slope from the linear relationship (SLlin), equal to
π γ
+
v
md k
16
3(1 )
0
2
eff
3
3 . Example plots of the linear relationship are given in
Supporting Information S7. Calculated values of γeff, r*, and i*
for the range of concentrations and compositions used are
displayed in Table 3.
3.4.1. Eﬀective Interfacial Tension. Calculated γeff values
showed a marked decrease as the supersaturation and H2O
content decreased. The compositional eﬀect on γeff correlates
with the solubility of the system, with a lower solubility
attributed to a higher γeff.
44 Furthermore, a higher rate of
decrease in γeff was observed for higher H2O contents, with the
rate decreasing along with the H2O content, showing a similar
trend to induction time results. This result provides evidence
that it may be possible to extrapolate γeff values over the
compositional range, even to the single solvent system
boundaries; however, further work is clearly needed to probe
this possibility.
Sullivan et al.45 and Toroz et al.35 recently reported values of
γeff for pABA in acetonitrile, 2-propanol, ethyl acetate, and
ethanol, respectively, using isothermal experimental method-
ologies, in the range of 1.33−2.44 mJ m−2 over 1.08 < S < 1.35
and 0.85−1.31 mJ m−2 over the smaller range of 1.04 < S <
1.15, respectively. The calculated values of Sullivan et al.
compare well with those calculated in a similar supersaturation
range in this study, providing conﬁdence in the results
obtained. However, these studies were concerned with single
solvent systems, and to the authors’ knowledge, no current
open literature source provides details of values of γeff for
EtOH/H2O mixed systems. Jiang and Ter Horst
42 previously
studied a similar compound in a similar solvent system, m-
aminobenzoic acid in mixed EtOH/H2O solution, and
determined the value of γeff for this system to be 8.7 mJ
m−2, which correlates well with the higher γeff values calculated
in this study.
Interestingly, although it has been previously found that for
pABA in EtOH solutions a lower pABA concentration
correlates to lower values of γeff,
35 the same trend was not
followed for these results. Instead, the opposite occurs, with a
lower concentration correlating to a higher γeff. This result
suggests that either the supersaturation or the compositional
eﬀects dominate γeff, although it is not possible to disentangle
these factors under this experimental procedure because of the
supersaturation and composition being intrinsically linked.
Furthermore, induction time data over single temperatures,
that is, multiple compositions, was studied. Figure 9 displays
data collected for a single temperature of 299 K. For
temperatures of 295−301 K, there were two linear relation-
ships found for the experimental data, showing two distinct
slopes. This is indicative of a mechanistic change in the
nucleation of pABA from the mixed solvent system, changing
from HEN to HON as the supersaturation reached a suﬃcient
level. This ﬁnding has been observed in a number of research
studies with critical supersaturations attributed to this
mechanistic change being varied depending upon the system
of study. Kim and Kim12 found the HEN to HON critical
Table 3. Kinetic Parameters, γeff, r*, and i*, Calculated from Antisolvent Induction Time Experiments as a function of Solution
Concentration and Composition over a Range of Supersaturations
ﬁnal solution concentration
(g kg−1)
EtOH/H2O solvent ratio
(wt %)
temperature range
(K)
γeff
(mJ m−2)
supersaturation
range r* (nm)
i*
(molecules)
34.4 17:83 293−301 8.39 3.7−2.6 0.53−0.71 4−9
40.7 21:79 293−301 7.86 3.2−2.2 0.56−0.78 4−12
47.0 24:76 293−301 6.39 2.7−2.0 0.52−0.76 4−11
53.6 27:73 293−301 5.29 2.4−1.7 0.50−0.78 3−12
60.3 31:69 293−301 4.50 2.1−1.5 0.51−0.85 3−16
67.2 34:66 293−301 3.35 1.8−1.4 0.46−0.87 2−17
74.2 38:62 295−301 2.77 1.5−1.2 0.54−0.1.08 4−32
81.4 41:59 295−301 2.11 1.4−1.1 0.55−1.51 4−87
88.9 45:55 295−299 2.32 1.3−1.1 0.84−1.98 15−196
Figure 9. Induction time vs supersaturation for single temperature
and multiple composition solutions of pABA in EtOH/H2O mixtures
for solutions at 299 K.
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supersaturation level of S = 1.7 for the aqueous sodium
chloride solution using methanol as an antisolvent, whereas
Söhnel and Mullin46 found S = 20 for reaction crystallization of
calcium carbonate from the aqueous sodium carbonate
solution. In the case of pABA in EtOH/H2O solutions in
this study, the change occurred at S ≈ 1.5.
This slope change was not observed at the set temperature
of 293 K, which is due to the lowest level of supersaturation
achieved being above the S ≈ 1.5 threshold.
3.4.2. Critical Nucleus Radius and Number of Molecules
in the Critical Nucleus. Values of r* and i* both showed a
similar trend to the obtained induction time measurements as a
function of supersaturation for pABA in EtOH/H2O mixed
solutions, that is, lower values correlate with higher super-
saturations (Figure 10), which is a trend previously observed
with pABA in ethanolic solutions35 and is expected with the
supersaturation dependence (eqs 10 and 11). Additionally, the
nonlinear trend is also consistent with smaller changes in
values observed at higher supersaturations and larger variation
achieved at lower supersaturations. However, a higher
supersaturation did not solely dictate r* and i*, as lower
values of r* and i* were determined at lower supersaturations
in some cases. This is compositional dependency, as the values
of γeff varied with the solubility of the systems studied, as
described previously. This indicates that although super-
saturation has a strong eﬀect on the size of the critical nucleus,
the composition has a larger eﬀect because of the γeff associated
with the formation of a critical nucleus.
Values of i* as low as 2 and 3 were calculated for this system
at relatively high supersaturations and at certain compositions.
In a previous study by this research group,35 it was determined
through small-angle X-ray studies that stable dimers are formed
in equilibrium with pABA in the EtOH solution, which is
suggestive that i* should be larger than 2, otherwise critical
nuclei would exist in an undersaturated state. Nevertheless, this
is suggestive of a nonclassical nucleation route, and as such, the
use of CNT, as the analysis methodology in this study, can
determine that i* = 2. Furthermore, in the previously
highlighted study, an isothermal methodology was also used
to determine key nucleation parameters and calculated i*
values as low as 3 using CNT at lower supersaturations than
were achieved in this current study, giving conﬁdence in the
results obtained here under a CNT methodology.
4. CONCLUSIONS
4.1. Conclusions of This Study. Overall, a comprehensive
experimental investigation was made, introducing a simple
methodology to accelerate crystal nucleation and enable key
kinetic parameters to be determined, which would otherwise
be unachievable through conventional crystallization methods,
while also providing a possibility for a future predictive ability
of the nucleation of slowly nucleating systems.
A route to the accelerated nucleation of pABA in ethanol/
water (EtOH/H2O) mixed solvent solutions, using antisolvent
crystallization, was presented using an “isothermal by design”
approach. Supersaturations that were accessible through the
IbD methodology of this system were higher than could be
achieved through traditional crystallization methods, achieving
S > 4. Initial solubility studies determined that small additions
of H2O to pABA in EtOH solutions increased the solubility,
but further additions decreased the solubility. All solutions of
pABA in the EtOH/H2O mixed solvent solution were less than
ideal.
The enthalpy of mixing upon addition of H2O as an
antisolvent had a dramatic eﬀect on the solution temperature
and as such the induction time results. Control of antisolvent
addition temperature, through calorimetry calibrations, en-
sured that the IbD experiments provided the relevant
information for accurate and comparable nucleation kinetic
analysis. Induction times were controlled with ease, with
signiﬁcant changes from solutions at low supersaturations and
high supersaturations by 4 orders of magnitude. The high
driving force to nucleation for solutions at high super-
saturations reduced the standard deviation of induction time
results when compared to that at low supersaturation
conditions.
Nucleation kinetics of a range of solution compositions and
concentrations were determined from the obtained exper-
imental data. Values of γeff decreased with decreasing
supersaturation and H2O content and increasing concen-
tration. The observed nonlinear trend of changing γeff with
composition was similar to that observed for induction time
measurements. A change of nucleation mechanism from HEN
to HON was found as the supersaturation was increased to a
critical value of around 1.5. Values of r* and i* both showed an
expected trend with respect to an increased supersaturation
being met with smaller critical nucleus sizes. However, the
results demonstrated that r* and i* were also compositionally
dependent, with supersaturation not solely determining the
critical nucleus size, showing that solubility plays a large role in
the nucleation kinetics of pABA crystallizing from ethanol/
water mixtures.
4.2. Future Work and Current Limitations. This study
has detailed a useful and novel methodology for determining
key nucleation parameters more eﬀectively over a vast range of
supersaturations. However, it is currently subject to certain
limitations and could be improved further.
One limitation of using the current system is the previously
highlighted solubility of pABA in mixed EtOH/H2O solvents.
This is due to an increased pABA solubility upon small
additions of H2O to EtOH solvent, limiting compositions
accessible to solely increase supersaturations, limiting the
Figure 10. r* (solid objects) and i* (hollow objects) vs super-
saturation from the data obtained at a ﬁnal solution concentration of
34.4 g pABA kg−1 solvent mixture (black ■/blue □) and a ﬁnal
solution concentration of 67.2 g pABA kg−1 solvent mixture (black
●/blue ○). Break applied to graph between 1.9 and 2.4.
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supersaturations that could be achieved in the allowable
working solution volume of the experimental apparatus used.
Many other systems would not be subject to this limitation
however, such as α-lactose in isopropanol/water and acetone/
water mixtures.47
Another limitation is that in order to use the IbD
methodology for accelerated nucleation studies, a “reasonable”
solubility is required for the initial solvent with the second
solvent having a much lower solubility, as highlighted in the
workﬂow given in Figure 1. However, this could easily be
mitigated by continuous crystallization IbD methodologies,
where the issue of solubility would be negated by the low
volumes mixed at one instance, such as use with T-mixer
geometries.12
Furthermore, supersaturations were limited under this
system of study as a minimum detection time of 1 s was
applicable for the experimental apparatus used. Therefore, if
diﬀerent apparatus and/or process analytical techniques (PAT)
were used, then resolution of results could be improved.
Nevertheless, systems that nucleate slower than the one in this
study would not be aﬀected by this limitation, and detection
could be more accurate.
Induction time data can be dependent upon the stochastic
nature of nucleation and as such can be aﬀected by relatively
high standard deviations of repeats, as discussed in Section 3.3.
This indicates that crystallization parameters calculated from
induction data can be subject to some variability. Further use
of PAT to determine the point of detectable nucleation more
accurately, such as use of complimentary Fourier transform
infrared spectroscopy,48 UV/vis,49 microscopy,50 and so forth,
could ensure that key crystallization parameters are calculated
more accurately; however, at the scales used for the current
study (1 mL) and the experimental apparatus, these
parameters are not applicable.
The calculated values of γeff showed a trend in decreasing
value alongside a decrease in H2O solvent content. This trend
needs to be further studied to understand if it is possible to
extrapolate calculated values of γeff to various other solvent
compositions. Furthermore, a statistical analysis of results
could provide an avenue in which to model the eﬀect of
supersaturation on induction time as well as the standard
deviations associated with the induction time measurements.
4.3. Potential for Transferring IbD Methodology to
Industrial Scales. The methodology outlined in this study
would be useful in an industrial R&D environment, enabling
key crystallization parameters to be determined more
accurately prior to large operation, aiding in improved large-
scale operation and greater control of product performance,
particularly with respect to the physical stability of materials,
such as undiscovered polymorphs. Furthermore, current tests
to predict nucleation events of slowly nucleating systems
involve large timescales for experiments, which hinder the
progression of products to manufacture and market. This
methodology would speed up this step and enable a product to
get to market quicker.
Also, the methodology provides clarity on the large eﬀect
that antisolvent addition can have upon otherwise well-
controlled solution conditions, which, given the larger volumes
used at industrial scales, can be even more problematic. This
important aspect of the methodology highlights the fact that
the antisolvent temperature must be oﬀset in comparison to
the solution temperature in order to ensure as accurate
solution conditions as possible and, as such, greater product
control, regardless of scale or industry application.
Nevertheless, the addition of antisolvent at controlled
temperatures did cause slight heating/cooling eﬀects to the
“isothermal” solution, but as described previously, this was
negligible and quick to return to the solution temperature at
the scale studied. However, at larger scales, this could be more
problematic and a longer time period to return to the set
solution temperature could occur. This could be controlled
through very accurate antisolvent addition calorimetry
calibrations, but it should be noted that this slight eﬀect is
much smaller than would occur without the IbD methodology
in place.
Furthermore, issues with cold spots, as alluded to previously,
and inhomogeneous mixing at industrial scales could be
problematic with the IbD methodology outlined. However,
these issues can be overcome with appropriate internals to
ensure that homogeneous solutions are formed, which could
be achieved through baﬄes, correct internals material choice,
and rotation speed.32,33 Also, manipulation of antisolvent
addition technique, such as an antisolvent distributor or
sparging, which is currently under research, could overcome
these issues. Furthermore, if this methodology is utilized with
gas antisolvent (GAS), then issues with mixing would be
negligible.51 This could also be negated by continuous
crystallization processes,52,53 where mixing can be extremely
rapid in a much smaller volume.
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■ NOMENCLATURE
A, pre-exponential factor
c, absolute solute concentration (m−3)
c*, saturation concentration (m−3)
cs, solution concentration at the crystal solution interface
(m−3)
d, dimensionality of crystal growth
d0, molecular diameter (m)
fe*, frequency of monomer attachment to the nucleus at Δμ
= 0 (1 s−1)
fe,s, frequency of molecular attachment per growth site at Δμ
= 0 (1 s−1)
i*, number of molecules in the critical nucleus
J, rate of nucleation (1 m−3 s−1)
k, Boltzmann constant (J K−1)
kv, crystallite growth shape factor
m, crystallite growth exponent
q, heating/cooling rate (K min−1)
R, ideal gas constant (J mol−1 K−1)
r, nucleus radius (m)
r*, critical nucleus radius (m)
S, supersaturation
T, temperature (K)
Tc, crystallization temperature (K)
Tc,l, crystallization temperatures at the kinetic limit (K)
Tdiss, dissolution temperature (K)
Te, equilibrium saturation temperatures (K)
v0, volume occupied by a solute molecule in a crystal (m
3)
x, molar solubility
xideal, ideal molar solubility
z, Zeldovich factor
αdet, fraction of detectable crystallized volume
ΔG, Gibbs free energy (kJ mol−1)
ΔHdiss, enthalpy of dissolution (kJ mol−1)
ΔSdiss, entropy of dissolution (kJ K−1 mol−1)
Y, activity coeﬃcient
γ, interfacial tension (mJ m−2)
γeff, eﬀective interfacial tension (mJ m
−2)
τ, induction time (s)
■ REFERENCES
(1) Khan, S.; Ma, C. Y.; Mahmud, T.; Penchev, R. Y.; Roberts, K. J.;
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